Compounding is the process of creating a customized medication to meet the specific needs of a patient. Lemonaid Health works with state-licensed compounding pharmacies to offer compounded semaglutide.

Compounded semaglutide is administered via subcutaneous injection. Your healthcare provider will instruct you on how to properly inject the medication. It is important to follow the dosing schedule and instructions provided to achieve the best results and minimize side effects. Injection should only occur 1 time per week. Dosage schedules at different frequencies are against safety recommendations.

Weight loss injections, such as those containing GLP-1 agonists, work by mimicking the hormone GLP-1, which helps regulate appetite and blood sugar levels. These injections slow gastric emptying and increase feelings of fullness, potentially leading to weight loss.

The rate and amount of weight loss varies depending on the individual's starting weight, adherence to the program, and specific medications used. On average, patients on GLP-1 medication can lose 15% of their body weight in a year.* It is important to remember that results and timelines can vary.

New England Journal Of Medicine — *In a 68-week placebo-controlled study of 1,961 obese and overweight non-diabetic adults with weight-related conditions, those on semaglutide lost on average 14.9% of their weight as opposed to 2% of the placebo group. Both groups followed a reduced-calorie diet, increased physical activity, and monthly nutritional counseling. Starting semaglutide (Wegovy®) dosage was 0.25mg per week, increasing to 2.4mg. The trial was overseen and sponsored by Novo Nordisk.

Lemonaid Health offers access to compounded semaglutide, made in State Board of Pharmacy licensed sterile compounding pharmacies that are FDA-inspected 503(b) outsourcing facilities. Our compounded semaglutide offering is the base form of semaglutide – not the sodium or acetate ("salt") versions.

While facilities making compounded medications are strictly regulated for certain quality practices, the compounded medications themselves are not approved or evaluated by the FDA for safety, effectiveness, or quality.

GLP-1 medications may cause side effects including nausea, vomiting, diarrhea, constipation, and abdominal pain. Less common side effects include headache, fatigue, and dizziness. In rare cases, more serious side effects such as pancreatitis, kidney problems, bowel obstruction, or allergic reactions can occur.

Always discuss potential side effects with a healthcare provider.

The cost of your medication will depend on the membership term and the prescribed medication. Monthly membership terms are $49/month.

For compounded tirzepatide: Monthly: $299 per month (billed separately)

For compounded tirzepatide microdoses: Monthly: $199 per month (billed separately)

For compounded semaglutide: Monthly: $299 per month (billed separately)

Other medications, such as Metformin ($90/ 3 months), Ozempic® ($1,199/month) and Wegovy® ($1,599/month), are also billed separately and are not included in the membership plans.

Zepbound single-dose vials are offered via LillyDirect and are available as a cash pay-only offering starting at $299/mo for the 2.5 mg dose. LillyDirect has the ability to change the price. Unlike our other weight loss medication options we offer, Zepbound single-dose vials are delivered, charged, and managed separately via LillyDirect.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Novo Nordisk is a registered trademark of Novo Nordisk A/S. Zepbound™ is a registered trademark of Eli Lilly and Company.